cafepharmaDec 12, 2023
Pfizer reveals reorganization, executive departure as it gets ready to close $43B Seagen buyout -- AstraZeneca buys into RSV vaccine market with potential $1.1B Icosavax purchase --US diabetes patients face delays as insurers tighten Ozempic coverage --http://bit.ly/w28kSd #pfizer #reorganization #seagen #rsv #vaccines #astrazeneca #mergersandacquisition #diabetes #novonordisk #ozempic #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
Cafepharma

Cafepharma is a site for the pharmaceutical/medical industry. Our scope includes pharmaceutical, device, biotech, laboratory, animal health, dental, etc. We have curated daily news headlines, active forums where users can post anonymously, job listings and more.

Cafepharma
Börsen-ZeitungOct 20, 2023
#Pfizer kauft ##Seagen: #EU-Kommission genehmigt Milliardenübernahme
https://www.boersen-zeitung.de/startseite/pfizer-kauft-seagen-eu-kommission-genehmigt-milliardenuebernahme-2?utm_campaign=mastodon&utm_source=mastodon&utm_medium=Digital
cafepharmaOct 18, 2023
Seagen, Astellas and Merck knock it out of the park with Padcev-Keytruda combo in bladder cancer-- BrainStorm eyes FDA meeting to find path for rejected ALS drug after withdrawing application --Amazon will start delivering prescriptions by drone -- See more on our front page news http://bit.ly/w28kSd #seagen #astellas #merck #keytruda #esmo #bladdercancer #als #fda #amazon #drones #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
Cafepharma

Cafepharma is a site for the pharmaceutical/medical industry. Our scope includes pharmaceutical, device, biotech, laboratory, animal health, dental, etc. We have curated daily news headlines, active forums where users can post anonymously, job listings and more.

Cafepharma
Benjamin Carr, Ph.D. 👨🏻‍💻🧬May 4, 2023
#Biotech #MandA gets off to a 'blistering' start in 2023, as insiders predict surge in deals
Already, #biopharma companies have tallied $64 billion in #mergers and #acquisitions deals this year. In the last few weeks alone, #Pfizer said it will pay $43 billion for #Seagen, #Merck agreed to acquire #PrometheusBiosciences for $10.8 billion, and #GSK said it will buy #BellusHealth for $2 billion. It’s a “blistering” pace on track for $300 billion by year’s end!!
https://endpts.com/biotech-ma-gets-off-to-a-blistering-start-in-2023-as-insiders-predict-surge-in-deals/ #capitalism
Biotech M&A gets off to a 'blistering' start in 2023, as insiders predict surge in deals

Big drugmakers have started 2023 with their checkbooks out, signing several multibillion-dollar takeovers in what some industry insiders see as the start of an M&A surge focused on snagging blockbuster drugs. The upswing in deals follows a year of falling stock prices and startups that have struggled to access private

Endpoints News
Börsen-ZeitungMar 14, 2023
#Pfizer übernimmt den Krebsspezialisten #Seagen
https://www.boersen-zeitung.de/unternehmen-branchen/pfizer-uebernimmt-den-krebsspezialisten-seagen-4377d402-c19f-11ed-a9f0-51ff8dd96ac2?utm_campaign=mastodon&utm_source=mastodon&utm_medium=Digital
Pfizer übernimmt den Krebsspezialisten Seagen

Der US-Arzneimittelhersteller plant eine Übernahme des Biotechunternehmens Seagen. Eine der größten Übernahmen in der Pharmabranche seit Jahren scheint möglich.

Börsen Zeitung
Börsen-ZeitungFeb 27, 2023
#Pfizer schaut sich #Seagen an
https://www.boersen-zeitung.de/unternehmen-branchen/pfizer-schaut-sich-seagen-an-4feb6b6e-b690-11ed-9cc6-3ff779a47ded?utm_campaign=mastodon&utm_source=mastodon&utm_medium=Digital
Pfizer schaut sich Seagen an

Der US-Pharmakonzern Pfizer hat offenbar ein Auge auf das Biotechunternehmen Seagen geworfen. Gespräche über eine potenzielle Übernahme befänden sich noch in einer frühen Phase, berichtet das „Wall Street Journal“ (WSJ).

Börsen Zeitung
ZeroTr0llJan 10, 2023

Kim Schrier April 16, 2018...
"There is absolutely too much money in American politics today, and it’s hurting our entire system,” said Dr. Schrier. “We will never have a government that works for everyone until we reduce the influence of corporate interests in our politics. This pledge marks just the beginning of the work I plan to do in Congress to limit the influence of corporate money in politics.”

Her top contributions 2017 - 2022

University of Washington - $430,195
#Microsoft Corp - $384,442
#Amazon.com - $200,765
Democracy Engine - $192,083
Virginia Mason Medical Center $152,897
#Boeing Co. - $82,956
#Alphabet Inc - $75,829
#Valve Corp - $68,690
#Meta - $65,285
#Seagen Inc - $59,787
#JStreetPAC - $51,881

Great job #kimschrier in keeping #corporate #influence out of our #congress